Paragon Capital Management LTD Eli Lilly & CO Transaction History

Paragon Capital Management LTD

$487 Million
Q3 2024

A detailed history of Paragon Capital Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Paragon Capital Management LTD holds 1,421 shares of LLY stock, worth $1.06 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,421

Previous 1,419 0.14%

Holding current value

$1.06 Million

Previous $1.28 Million 2.02%

% of portfolio

0.26%

Previous 0.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $1,544 - $1,920	2 Added 0.14%	1,421 $1.26 Million
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $13,772 - $17,271	19 Added 1.36%	1,419 $1.28 Million
Q1 2024 Apr 11, 2024	SELL	$592.2 - $792.28 $14,805 - $19,807	-25 Reduced 1.75%	1,400 $1.09 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $84,030 - $99,060	-160 Reduced 10.09%	1,425 $830,000
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $8,694 - $11,986	20 Added 1.28%	1,585 $851,000
Q2 2023 Jul 11, 2023	BUY	$350.74 - $468.98 $350 - $468	1 Added 0.06%	1,565 $733,000
Q1 2023 Apr 13, 2023	BUY	$310.63 - $364.82 $621 - $729	2 Added 0.13%	1,564 $537,000
Q4 2022 Jan 17, 2023	SELL	$321.55 - $374.67 $17,042 - $19,857	-53 Reduced 3.28%	1,562 $0
Q3 2022 Oct 14, 2022	BUY	$296.48 - $337.87 $592 - $675	2 Added 0.12%	1,615 $522,000
Q2 2022 Jul 18, 2022	BUY	$278.73 - $327.27 $557 - $654	2 Added 0.12%	1,613 $523,000
Q1 2022 Apr 19, 2022	BUY	$234.69 - $291.66 $704 - $874	3 Added 0.19%	1,611 $461,000
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $3,597 - $4,464	-16 Reduced 0.99%	1,608 $444,000
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $443 - $545	2 Added 0.12%	1,624 $375,000
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $541 - $700	3 Added 0.19%	1,622 $372,000
Q1 2021 Apr 21, 2021	BUY	$164.32 - $212.72 $328 - $425	2 Added 0.12%	1,619 $303,000
Q4 2020 Jan 26, 2021	BUY	$130.46 - $172.63 $391 - $517	3 Added 0.19%	1,617 $273,000
Q3 2020 Oct 22, 2020	SELL	$146.22 - $169.13 $14,037 - $16,236	-96 Reduced 5.61%	1,614 $239,000
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $409 - $492	3 Added 0.18%	1,710 $281,000
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $357 - $442	3 Added 0.18%	1,707 $237,000
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $182,191 - $225,660	1,704 New	1,704 $224,000
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $187,567 - $218,938	-1,693 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$111.31 - $131.02 $188,447 - $221,816	1,693 New	1,693 $220,000
Q4 2018 Jan 29, 2019	SELL	$105.9 - $118.64 $199,939 - $223,992	-1,888 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$85.86 - $107.31 $162,103 - $202,601	1,888 New	1,888 $203,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LTD with notifications on news.

Account

Paragon Capital Management LTD Eli Lilly & CO Transaction History